Saxena R K, Adler W H
J Immunol. 1979 Aug;123(2):846-51.
Natural killer activity of spleen cells obtained from different strains of mice against the human myeloid leukemia cell line, K562, and two mouse cell lines P815 and L1210 was measured by using the 4-hr chromium release assay. The level of cytotoxic activity of spleen cells against the K562 target was usually less than 4% lysis. However, treatment of the spleen cells with a specific anti-H-2 antiserum resulted in a dose-dependent augmentation of the degree of lysis of K562 cells. The augmentation of cytotoxic activity could be obtained by pretreatment of the spleen cells with antisera or by directly adding the antisera to the cytotox-incubation medium. Anti-thy-1 and anti-immunoglobulin antisera had no enhancing effect under similar conditions. The specific alloantisera-treated spleen cells did not show any increase in cytotoxicity against P815 and L1210 target cells. Spleen cells responsible for the alloantiserum-mediated augmentation of cytotoxicity against K562 cells appear to be different from T or B cells as indicated by their resistance to anti-thy-1 and complement treatment and lack of adherence to nylon wool columns.
通过4小时铬释放试验,测定了从不同品系小鼠获得的脾细胞对人髓性白血病细胞系K562以及两种小鼠细胞系P815和L1210的自然杀伤活性。脾细胞对K562靶细胞的细胞毒活性水平通常低于4%的裂解率。然而,用特异性抗H-2抗血清处理脾细胞会导致K562细胞裂解程度呈剂量依赖性增强。细胞毒活性的增强可以通过用抗血清预处理脾细胞或直接将抗血清加入细胞毒孵育培养基来实现。在类似条件下,抗Thy-1和抗免疫球蛋白抗血清没有增强作用。经特异性同种抗血清处理的脾细胞对P815和L1210靶细胞的细胞毒性没有任何增加。如对抗Thy-1和补体处理有抗性以及不黏附于尼龙毛柱所示,负责同种抗血清介导的对K562细胞细胞毒性增强的脾细胞似乎不同于T细胞或B细胞。